These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 22341272)

  • 21. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
    Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
    World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study.
    Bouzouita A; Rehaiem A; Saadi A; Zaghbib S; Chakroun M; Ayed H; Ferjani A; Derouiche A; Boubaker IB; Slama MRB
    Int Urol Nephrol; 2024 Aug; 56(8):2495-2502. PubMed ID: 38448785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis.
    Ozgur A; Asif Y; Gokhan A; Berrin T; Cenk G; Bulent E; Onur D; Meftun C; Haluk V; Hulya C; Turhan C
    Arch Esp Urol; 2017 Dec; 70(10):852-858. PubMed ID: 29205165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: A prospective randomized study.
    Fahmy A; Rhashad H; Mohi M; Elabbadie A; Kotb A
    Prostate Int; 2016 Sep; 4(3):113-7. PubMed ID: 27689069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study.
    Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK
    J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.
    Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK
    Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
    Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
    Cussans A; Somani BK; Basarab A; Dudderidge TJ
    BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
    Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy.
    Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P
    J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy.
    Li CK; Tong BCY; You JHS
    Int J Infect Dis; 2016 Feb; 43():7-12. PubMed ID: 26686941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.
    Hwang EC; Jung SI; Seo YH; Jeong SH; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2015 Apr; 47(4):595-601. PubMed ID: 25712677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.